The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

COGT FINANCIAL STATEMENTS

Cogent Biosciences Inc — balance sheet, income statement and cash flow trends

COGTCogent Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-2.3 M $ · -Infinity%Operating Income-389.1 M $ · -Infinity%Pre-tax Income-377.2 M $ · -Infinity%Net Income to Owners-377.2 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-2.3 M $—
Operating Income-389.1 M $—
EBITDA-381.1 M $—
Net Income to Owners-377.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets834.5 M
  • Equity532.4 M $64%
  • Current Liabilities59.3 M $7%
  • Long-term Liabilities242.9 M $29%

Key Figures

YoY change
Total Assets834.5 M $+203.7%
Total Liabilities302.2 M $+152.3%
Total Equity532.4 M $+243.4%
Cash & ST Investments792.3 M $+233.1%
Total Debt244.3 M $+302.7%
Net Debt63.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-750 M-500 M-250 M0-307.5 M $Operating-500 M $Investing861.5 M $Financing54 M $Net Change

Key Figures

YoY change
Operating Cash Flow-307.5 M $—
Capital Expenditures1.7 M $+64.1%
Free Cash Flow-309.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on COGT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.